Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Form 8.3 - DECHRA PHARMACEUTICALS PLC

14 Nov 2023 13:23

RNS Number : 4247T
Barclays PLC
14 November 2023
ย 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

ย 

Barclays PLC.

(b)

Owner or controller of interest and short

ย 

ย 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

ย 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

ย 

ย 

offeror/offeree, state this and specify identity of

ย 

offeror/offeree:

(e)

Date position held/dealing undertaken:

13 Nov 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

ย 

ย 

ย 

disclosures in respect of any other party to the offer?

ย 

ย 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

ย 

ย 

to which the disclosure relates following the dealing(if any)

ย 

Class of relevant security:

1p ordinary

ย 

Interests

Short Positions

ย 

Number

(%)

Number

(%)

(1)

Relevant securities owned

ย 

ย 

ย 

ย 

ย 

and/or controlled:

ย 

ย 

7,468,068

6.56%

1,844,483

1.62%

(2)

Cash-settled derivatives:

ย 

ย 

ย 

ย 

ย 

and/or controlled:

ย 

ย 

1,179,952

1.04%

7,397,096

6.49%

(3)

Stock-settled derivatives (including options)

ย 

ย 

ย 

ย 

ย 

and agreements to purchase/sell:

ย 

ย 

0

0.00%

0

0.00%

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

TOTAL:

ย 

ย 

8,648,020

7.59%

9,241,579

8.11%

(b)

Rights to subscribe for new securities (including directors and other executive

ย 

ย 

options)

ย 

ย 

ย 

ย 

ย 

ย 

Class of relevant security in relation to

ย 

ย 

ย 

ย 

which subscription right exists

ย 

ย 

ย 

ย 

Details, including nature of the rights

ย 

ย 

ย 

ย 

concerned and relevant percentages:

ย 

ย 

ย 

ย 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

ย 

ย 

ย 

ย 

ย 

Class of relevant

Purchase/sale

Number of

Price per unit

security

ย 

securities

ย 

1p ordinary

Purchase

21,428

37.8025 GBP

1p ordinary

Purchase

21,279

37.8023 GBP

1p ordinary

Purchase

13,693

37.8619 GBP

1p ordinary

Purchase

1,510

37.8583 GBP

1p ordinary

Purchase

1,429

37.8543 GBP

1p ordinary

Purchase

907

37.8448 GBP

1p ordinary

Purchase

756

37.8558 GBP

1p ordinary

Purchase

753

37.8573 GBP

1p ordinary

Purchase

524

37.8400 GBP

1p ordinary

Purchase

388

37.8600 GBP

1p ordinary

Purchase

383

37.8598 GBP

1p ordinary

Purchase

346

37.7800 GBP

1p ordinary

Purchase

200

37.8800 GBP

1p ordinary

Purchase

107

37.8500 GBP

1p ordinary

Purchase

51

37.9000 GBP

1p ordinary

Sale

6,102

37.8620 GBP

1p ordinary

Sale

3,310

37.8176 GBP

1p ordinary

Sale

2,560

37.8478 GBP

1p ordinary

Sale

1,252

37.8400 GBP

1p ordinary

Sale

416

37.7800 GBP

1p ordinary

Sale

107

37.8500 GBP

1p ordinary

Sale

68

37.8600 GBP

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(b)

Cash-settled derivative transactions

ย 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

ย 

reference

unit

security

ย 

ย 

securities

ย 

1p ordinary

SWAP

Long

2,560

37.8478 GBP

1p ordinary

SWAP

Long

4,306

37.8227 GBP

1p ordinary

CFD

Short

18

37.8133 GBP

1p ordinary

SWAP

Short

107

37.8500 GBP

1p ordinary

SWAP

Short

169

37.8800 GBP

1p ordinary

SWAP

Short

323

37.8129 GBP

1p ordinary

SWAP

Short

383

37.8598 GBP

1p ordinary

SWAP

Short

2,575

37.8348 GBP

1p ordinary

SWAP

Short

2,871

37.7800 GBP

1p ordinary

SWAP

Short

3,601

37.8609 GBP

1p ordinary

SWAP

Short

4,000

37.7837 GBP

1p ordinary

SWAP

Short

5,009

37.8029 GBP

1p ordinary

SWAP

Short

9,940

37.7830 GBP

1p ordinary

SWAP

Short

13,693

37.8619 GBP

1p ordinary

SWAP

Short

13,739

37.8066 GBP

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(c)

Stock-settled derivative transactions (including options)

ย 

(i)

Writing, selling, purchasing or varying

ย 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

ย 

date

money

relevant

ย 

selling,

securities

per unit

ย 

ย 

paid/

security

ย 

varying etc

to which

ย 

ย 

ย 

received

ย 

ย 

ย 

option

ย 

ย 

ย 

per unit

ย 

ย 

ย 

relates

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(ii)

Exercising

ย 

ย 

ย 

ย 

ย 

ย 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

ย 

ย 

securities

unit

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(d)

Other dealings (including subscribing for new securities)

ย 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

ย 

ย 

applicable)

ย 

ย 

ย 

ย 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

ย 

Details of any indemnity or option arrangement, or any agreement or understanding,

ย 

ย 

formal or informal, relating to relevant securities which may be an inducement to deal

ย 

ย 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

ย 

to the offer or any person acting in concert with a party to the offer:

ย 

ย 

ย 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

ย 

Details of any agreement, arrangement or understanding, formal or informal, between

ย 

ย 

the person making the disclosure and any other person relating to:

ย 

ย 

(i) the voting rights of any relevant securities under any option; or

ย 

ย 

ย 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

ย 

ย 

any derivative is referenced:

ย 

ย 

ย 

ย 

ย 

ย 

NONE

(c)

Attachments

ย 

ย 

ย 

ย 

ย 

ย 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

14 Nov 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
RETEADFLFFNDFFA
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.